EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Chondrocyte Implantation

Isabella Jazrawi, Rushani K. Cameron, Raven Hollis, Stevie Tchako-Tchokouassi, Cody Perskin, Eric J. Strauss, Laith M. Jazrawi, Kirk A. Campbell

Surgeries · 23.03.2026 · 7 (1) · 40

DOI: 10.3390/surgeries7010040 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgeries, online erschienen am 23.03.2026. Verfasst von Isabella Jazrawi und 7 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: The aim of this study is to evaluate whether preoperative intra-articular corticosteroid injections (CSIs) are associated with an increased risk of reoperation following matrix-associated or autologous chondrocyte implantation (MACI/ACI). Secondary aims included comparing reoperation-free survival, patient-reported outcomes (PROMs), and patient acceptable symptom state (PASS) achievement.

Methods

A retrospective cohort study was conducted on adults undergoing primary MACI/ACI between 2011 and 2023 at a single academic institution. Patients with documented CSI status and ≥2 years of follow-up were included. Exclusion criteria were prior MACI/ACI, osteochondral allograft transplantation, multi-ligament reconstruction, or inadequate follow-up. Propensity score matching (2:1, no steroid/steroid) based on age, sex, BMI, laterality, procedure type, and prior surgery yielded 138 matched patients (92 no steroid, 48 steroid). The primary outcome was ipsilateral reoperation, analyzed as a binary outcome, with Kaplan–Meier reoperation-free survival and restricted mean survival time (RMST). PROMs and PASS achievement were also assessed. Statistical significance was set at p < 0.05.

Results

Baseline characteristics and follow-up (6.55 ± 3.74 vs. 6.73 ± 3.99 years; p = 0.80) were similar. Graft failure rates were identical (4.3% each; p = 1.00). Reoperation occurred in 21.7% of patients without CSI and 23.9% with CSI (p = 0.83). CSI was not associated with reoperation (adjusted OR 2.28; 95% CI 0.54–9.95; p = 0.26). No significant difference in reoperation-free survival or PROMs was observed.

Conclusions

Preoperative intra-articular corticosteroid injections were not associated with increased reoperation risk, inferior reoperation-free survival, or worse functional outcomes following MACI/ACI.

Zitieren

APA

Jazrawi, I., Cameron, R. K., Hollis, R., Tchako-Tchokouassi, S., Perskin, C., Strauss, E. J., Jazrawi, L. M., & Campbell, K. A. (2026). Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Chondrocyte Implantation. Surgeries, 7(1), 40. https://doi.org/10.3390/surgeries7010040

Vancouver

Jazrawi I, Cameron RK, Hollis R, Tchako-Tchokouassi S, Perskin C, Strauss EJ, et al. Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Chondrocyte Implantation. Surgeries. 2026;7(1):40. doi:10.3390/surgeries7010040

BibTeX
@article{Jazrawi2026,
  author = {Jazrawi, Isabella and Cameron, Rushani K. and Hollis, Raven and Tchako-Tchokouassi, Stevie and Perskin, Cody and Strauss, Eric J. and Jazrawi, Laith M. and Campbell, Kirk A.},
  title = {Preoperative Intra-Articular Corticosteroid Injection Is Not Associated with Inferior Reoperation or Patient-Reported Outcomes Following Chondrocyte Implantation},
  journal = {Surgeries},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {40},
  doi = {10.3390/surgeries7010040}
}
Kostenlos starten →